|
Ibuprofen EP Impurity L
|
布洛芬EP雜質(zhì)L
|
53949-53-4
|
|
Pinaverium Impurity A
|
匹維銨雜質(zhì)A
|
|
|
Etoricoxib
|
依托考昔
|
202409-33-4
|
|
Voriconazole EP Impurity B
|
伏立康唑EP雜質(zhì)B
|
182369-73-9
|
|
Tofacitinib Impurity N
|
托法替尼雜質(zhì) N
|
1260614-73-0
|
|
Tofacitinib Impurity J
|
托法替尼雜質(zhì) J
|
|
|
Irbesartan Impurity 13
|
厄貝沙坦雜質(zhì)13
|
|
|
Tofacitinib Impurity U
|
托法替尼雜質(zhì) U
|
1616760-97-4
|
|
Indacaterol Impurity 2
|
茚達特羅雜質(zhì)2
|
1026461-20-0
|
|
Irbesartan Related Compound A
|
厄貝沙坦相關化合物A
|
748812-53-5
|
|
Ibuprofen EP Impurity J
|
布洛芬EP雜質(zhì)J
|
65813-55-0
|
|
Donepezil EP Impurity F;Donepezil USP Related Compound A
|
多奈哌齊EP雜質(zhì) F；多奈哌齊USP相關化合物A
|
145546-80-1
|
|
Voriconazole
|
伏立康唑
|
137234-62-9
|
|
Irbesartan Impurity 12
|
厄貝沙坦雜質(zhì)12
|
160514-13-6
|
|
Tofacitinib Impurity F
|
托法替尼雜質(zhì) F
|
384338-23-2
|
|
Ibuprofen EP Impurity H
|
布洛芬EP雜質(zhì)H
|
2143535-25-3
|
|
Etoricoxib Impurity 7
|
依托考昔雜質(zhì)7
|
646459-39-4
|
|
Ibuprofen EP Impurity D
|
布洛芬EP雜質(zhì)D
|
938-94-3
|
|
Furosemide Impurity 1 HCl;Furfurylamine HCl
|
呋塞米雜質(zhì) 1 HCl;糠胺 HCl
|
4753-68-8
|
|
Donepezil Alkene Pyridine N-Oxide
|
多奈哌齊烯烴吡啶氮氧化物
|
2452407-68-8
|
|
Furosemide EP Impurity D
|
呋塞米EP雜質(zhì)D
|
5046-19-5
|
|
Pinaverium Bromide Impurity 3
|
匹維溴銨雜質(zhì)3
|
1126385-20-3
|
|
Valeric Acid;Valproic Acid EP Impurity A
|
戊酸；丙戊酸EP雜質(zhì)A
|
109-52-4
|
|
Furosemide
|
呋塞米
|
54-31-9
|
|
Etoricoxib Impurity 37
|
依托考昔雜質(zhì)37
|
58058-86-9
|
|
Tofacitinib Impurity 10
|
托法替尼雜質(zhì) 10
|
477600-74-1
|
|
Voriconazole USP Related Compound A
|
伏立康唑相關化合物A
|
137330-52-0
|
|
Ibuprofen EP Impurity E
|
布洛芬EP雜質(zhì)E
|
38861-78-8
|
|
Indacaterol Impurity 6 HCl
|
茚達特羅雜質(zhì)6鹽酸鹽
|
312753-53-0
|
|
Tofacitinib Impurity R
|
托法替尼雜質(zhì) R
|
479633-63-1
|
|
Tofacitinib Impurity 24
|
托法替尼雜質(zhì) 24
|
1092578-48-7
|
|
Ibuprofen EP Impurity Q
|
布洛芬EP雜質(zhì)Q
|
36039-35-7
|
|
Voriconazole Related Compound D
|
伏立康唑相關化合物D
|
|
|
Tofacitinib Impurity T
|
托法替尼雜質(zhì) T
|
1092578-43-2
|
|
Lenvatinib Impurity 13
|
侖伐替尼雜質(zhì)13
|
|
|
Ibuprofen EP Impurity I
|
布洛芬EP雜質(zhì)I
|
2143535-26-4
|
|
Tofacitinib Impurity C Citrate
|
托法替尼雜質(zhì) C 檸檬酸鹽
|
1092578-47-6
|
|
Pinaverium Bromide Impurity 2
|
匹維溴銨雜質(zhì)2
|
54370-00-2
|
|
Ibuprofen EP Impurity F
|
布洛芬EP雜質(zhì)F
|
65322-85-2
|
|
Indacaterol Impurity 7
|
茚達特羅雜質(zhì)7
|
435273-75-9
|
|
Irbesartan Impurity 6
|
厄貝沙坦雜質(zhì)6
|
138401-24-8
|
|
Tofacitinib Impurity L
|
托法替尼雜質(zhì) L
|
1675248-19-7
|
|
Tofacitinib Impurity I
|
托法替尼雜質(zhì) I
|
|
|
Tofacitinib Impurity W
|
托法替尼雜質(zhì) W
|
|
|
Pinaverium Bromide
|
匹維溴銨
|
53251-94-8
|
|
Tofacitinib Impurity X
|
托法替尼雜質(zhì) X
|
|
|
Voriconazole Impurity E
|
伏立康唑雜質(zhì)E
|
5872-08-2
|
|
Irbesartan
|
厄貝沙坦
|
138402-11-6
|
|
Furosemide Impurity 2
|
呋塞米雜質(zhì) 2
|
41332-59-6
|
|
Irbesartan Impurity 5
|
厄貝沙坦雜質(zhì)5
|
141745-36-0
|
|
Irbesartan Impurity 7
|
厄貝沙坦雜質(zhì)7
|
141745-71-3
|
|
Tofacitinib Impurity 39
|
托法替尼雜質(zhì) 39
|
923036-30-0
|
|
Irbesartan N-Trityl Impurity
|
厄貝沙坦N-三苯甲基雜質(zhì)
|
|
|
Valproic Acid Impurity F
|
丙戊酸雜質(zhì)F
|
|
|
Irbesartan Impurity 4
|
厄貝沙坦雜質(zhì)4
|
945540-26-1
|
|
Ibuprofen EP Impurity G
|
布洛芬EP雜質(zhì)G
|
|
|
Furosemide EP Impurity C
|
呋塞米EP雜質(zhì)C
|
3086-91-7
|
|
Furosemide EP Impurity B
|
呋塞米EP雜質(zhì)B
|
2736-23-4
|
|
Etoricoxib Impurity 36
|
依托考昔雜質(zhì)36
|
33963-58-5
|
|
Ibuprofen EP Impurity M
|
布洛芬EP雜質(zhì)M
|
60057-62-7
|
|
Etoricoxib N-Oxide
|
依托考昔氮氧化物
|
325855-74-1
|
|
Tofacitinib Impurity 9
|
托法替尼雜質(zhì) 9
|
477600-73-0
|
|
Tofacitinib Impurity 42
|
托法替尼雜質(zhì) 42
|
1092578-46-5
|
|
Irbesartan Impurity 9
|
厄貝沙坦雜質(zhì)9
|
1079997-01-5
|
|
Donepezil Impurity 2
|
多奈哌齊雜質(zhì)2
|
36517-91-6
|
|
Indacaterol Impurity 1
|
茚達特羅雜質(zhì)1
|
1403389-05-8
|
|
Tofacitinib Impurity V
|
托法替尼雜質(zhì) V
|
|
|
Donepezil N-Oxide
|
多奈哌齊N-氧化物
|
120013-84-5
|
|
Ibuprofen EP Impurity K
|
布洛芬EP雜質(zhì)K
|
43153-07-7
|
|
Ibuprofen EP Impurity P
|
布洛芬EP雜質(zhì)P
|
36039-36-8
|
|
Ibuprofen EP Impurity R
|
布洛芬EP雜質(zhì)R
|
102120-87-6
|
|
Ibuprofen EP Impurity O
|
布洛芬EP雜質(zhì)O
|
64451-76-9
|
|
Valproic Acid EP Impurity I
|
丙戊酸EP雜質(zhì)L
|
13310-75-3
|
|
Donepezil EP Impurity D
|
多奈哌齊EP雜質(zhì)D
|
4803-57-0
|
|
Ibuprofen Related Compound 1
|
布洛芬相關化合物1
|
75625-99-9
|
|
Indacaterol Impurity 5
|
茚達特羅雜質(zhì)5
|
173140-90-4
|
|
Indacaterol Maleate
|
馬來酸茚達特羅
|
753498-25-8
|
|
Etoricoxib Impurity 35
|
依托考昔雜質(zhì)35
|
300355-18-4
|
|
Tofacitinib Impurity P
|
托法替尼雜質(zhì) P
|
1252883-90-1
|
|
S-Ibuprofen-Acyl-beta-D-Glucuronide
|
S-布洛芬-?；?β-D-葡糖苷酸
|
98649-76-4
|
|
(S)-Indacaterol
|
(S)-茚達特羅
|
1235445-80-3
|
|
Propyl Ibuprofen
|
丙基布洛芬
|
|
|
Valproic Acid EP Impurity K
|
丙戊酸EP雜質(zhì)K
|
5343-52-2
|
|
Voriconazole EP Impurity D;Voriconazole Enantiomer
|
伏立康唑 EP 雜質(zhì) D；伏立康唑對映異構體
|
137234-63-0
|
|
Furosemide EP Impurity A
|
呋塞米EP雜質(zhì)A
|
4818-59-1
|
|
Ibuprofen Related Compound 2
|
布洛芬相關化合物2
|
67381-50-4
|
|
Etoricoxib Impurity 5 Lithium Salt
|
依托考昔雜質(zhì) 5 鋰鹽
|
1421227-96-4
|
|
Pinaverium Bromide Impurity 1
|
匹維溴銨雜質(zhì)1
|
|
|
Irbesartan Impurity 10;Irbesartan Dimer
|
厄貝沙坦雜質(zhì)10;厄貝沙坦二聚體
|
1346598-52-4
|
|
Voriconazole EP Impurity C
|
伏立康唑EP雜質(zhì)C
|
137234-88-9
|
|
Ibuprofen EP Impurity N
|
布洛芬EP雜質(zhì)N
|
3585-52-2
|
|
Tofacitinib Impurity Q
|
托法替尼雜質(zhì) Q
|
3680-69-1
|
|
Etoricoxib Impurity D
|
依托考昔雜質(zhì)D
|
221615-75-4
|
|
Tofacitinib Citrate
|
托法替尼枸櫞酸鹽
|
540737-29-9
|
|
Furosemide EP Impurity E
|
呋塞米EP雜質(zhì)E
|
50-84-0
|
|
Valproic Acid related compound B
|
丙戊酸相關化合物B
|
|
|
Furosemide EP Impurity F
|
呋塞米EP雜質(zhì)F
|
4793-38-8
|
|
Ibuprofen EP Impurity A
|
布洛芬EP雜質(zhì)A
|
66622-47-7
|
|
Etoricoxib Impurity 34
|
依托考昔雜質(zhì)34
|
|
|
Valproic Acid Related Compound A Sodium Salt
|
丙戊酸相關化合物A鈉鹽
|
76944-37-1
|
|
Etoricoxib Impurity 29
|
依托考昔雜質(zhì)29
|
5470-70-2
|